View More Recent Stories
-
Rezolute Inc. (RZLT): FDA Lifts Partial Clinical Holds on RZ358 for the Treatment of Congenital Hyperinsulinism and Authorizes U.S. Inclusion in Ongoing Phase 3 Study
-
Rezolute Inc. (RZLT) Files for 4.5M Share Offering by Selling Stockholders
-
Rezolute Inc. (RZLT) Announces FDA Clearance of IND Application for Phase 3 Study of RZ358
-
BTIG Starts Rezolute (RZLT) at Buy
-
Rezolute (RZLT) Announces Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
-
Rezolute Inc. (RZLT) Announces Proposed Share and Warrant Offering
